Enhancing patient safety with intelligent intravenous infusion devices: Experience in a specialty cardiac hospital

被引:4
作者
Wood, Jacqueline L. [1 ]
Burnette, Jeremy S. [1 ]
机构
[1] St Vincent Heart Ctr Indiana, Indianapolis, IN USA
来源
HEART & LUNG | 2012年 / 41卷 / 02期
关键词
Drug delivery; Infusion pumps; Intravenous systems; Patient safety; Safety software; TECHNOLOGY; IMPLEMENTATION; ERRORS;
D O I
10.1016/j.hrtlng.2011.07.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE: The study objective was to evaluate patient safety, increase nursing satisfaction, and affect economic factors through implementation of intelligent intravenous (IV) infusion devices in a specialty cardiac hospital. Intelligent IV infusion devices have been shown to decrease medication errors associated with inpatient infusions. METHODS: Intelligent IV infusion device evaluation and drug library creation were conducted by a multidisciplinary team within the hospital. Devices were then implemented into patient care, and the impact was analyzed over a 9,month period. RESULTS: Post-implementation data showed that compliance was approximately 100%. A total of 494 critical catches occurred over the study period, resulting in an estimated annual savings of $7,513,333. End-users became familiar with the new technology and recognized the increase in safety measures and time spent with patients. CONCLUSION: This evaluation suggests that intelligent IV infusion devices resulted in decreased costs and a safer environment for patients. Cite this article: Wood, J. L., & Bumette, J. S. (2012, MARCH/APRIL). Enhancing patient safety with intelligent intravenous infusion devices: Experience in A specialty cardiac hospital. Heart & Lung, 41(2), 173-176. doi:10.1016/j.hrtlng.2011.07.009.
引用
收藏
页码:173 / 176
页数:4
相关论文
共 12 条
  • [1] Use of failure mode and effects analysis in improving the safety of iv drug administration
    Adachi, W
    Lodolce, AE
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2005, 62 (09) : 917 - 920
  • [2] [Anonymous], PREVENTING MED ERROR
  • [3] Cassano A., 2006, HOSP PHARM, V41, P151
  • [4] Eskew J.A., 2002, HOSP PHARM, V37, P1179
  • [5] Impact of smart infusion technology on administration of anticoagulants (unfractionated heparin, argatroban, lepirudin, and bivalirudin)
    Fanikos, John
    Fiumara, Karen
    Baroletti, Steve
    Luppi, Carol
    Saniuk, Catherine
    Mehta, Amar
    Silverman, Jon
    Goldhaber, Samuel Z.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (07) : 1002 - 1005
  • [6] Hicks R.W., 2006, MEDMARX Data Report
  • [7] Standard drug concentrations and smart-pump technology reduce continuous-medication-infusion errors in pediatric patients
    Larsen, GY
    Parker, HB
    Cash, J
    O'Connell, M
    Grant, MJC
    [J]. PEDIATRICS, 2005, 116 (01) : E21 - E25
  • [8] Proceedings of a summit on preventing patient harm and death from i.V, 2008, AM J HLTH SYST PHARM, V65, P2367
  • [9] Rosenthal Kelli, 2004, Nurs Manage, V35, P49, DOI 10.1097/00006247-200405000-00015
  • [10] Siv-Lee L., 2007, HOSP PHARM, V42, P832